An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older

Detalles Bibliográficos
Publicado en:Drug Safety Vol. 47; no. 4; pp. 365 - 376
Autores principales: Dos Santos, Gaël, Devadiga, Raghavendra, Kim, Chun Soo, Bang, Joon
Formato: Journal Article
Publicado: Springer Nature Apr2024
Acceso en línea:Ver este registro en EBSCOhost